U.S. Physical Therapy (USPH) Aktievy
U.S. Physical Therapy, Inc. driver och förvaltar tillsammans med sina dotterbolag kliniker för öppenvårdsfysioterapi. Mer information
| Snöflinga Score | |
|---|---|
| Värdering | 3/6 |
| Framtida tillväxt | 3/6 |
| Tidigare resultat | 1/6 |
| Finansiell hälsa | 4/6 |
| Utdelningar | 3/6 |
USPH Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
U.S. Physical Therapy, Inc. Konkurrenter
Prishistorik och prestanda
| Historiska aktiekurser | |
|---|---|
| Aktuell aktiekurs | US$63.50 |
| 52 veckors högsta | US$93.50 |
| 52 veckors lägsta | US$58.19 |
| Beta | 1.16 |
| 1 månads förändring | 2.49% |
| 3 månaders förändring | -15.29% |
| 1 års förändring | -19.66% |
| 3 års förändring | -45.93% |
| 5 års förändring | -44.96% |
| Förändring sedan börsintroduktionen | 2,527.58% |
Senaste nyheter och uppdateringar
Analysartikel • Jun 20
U.S. Physical Therapy (USPH) Stock Could Be 32.4% Undervalued After Profit Growth
U.S. Physical Therapy (USPH) is back in focus after recent financial disclosures showed 7.89% year-over-year revenue growth and net profit rising 115.29%, while analyst opinions and technical signals currently point in different directions for the stock. See our latest analysis for U.S. Physical Therapy. Despite the latest revenue and net profit figures, U.S. Physical Therapy’s 1-year total shareholder return declined 12.6% and the 5-year total shareholder return fell 41.7%, indicating fading...
Uppdatering av berättelse • Jun 13
USPH: Hospital Alliances And Medicare Pricing Will Support Future Margin Upside
Analysts have lowered their price target on U.S. Physical Therapy to $90 from $103, citing somewhat lower profitability expectations and a higher projected net debt load following a mixed Q1 report. What's in the News From January 1, 2026 to March 31, 2026, U.S. Physical Therapy reported no share repurchases, with 0 shares bought for US$0 million under its existing buyback program (Key Developments).Uppdatering av berättelse • May 30
USPH: Hospital Alliances And Medicare Pricing Will Drive Future Margin Recovery
Analysts have trimmed their blended price target on U.S. Physical Therapy from about $107 to roughly $94, reflecting lower P/E assumptions and somewhat softer profitability expectations, along with higher net debt. They also note potential margin improvement supported by hospital alliances and improved Medicare rates.Seeking Alpha • May 22
U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade)
Summary U.S. Physical Therapy, Inc. has seen valuation multiples compress significantly despite continued revenue growth and new strategic initiatives. U.S. Physical Therapy reported Q1 2026 revenue of $198.3M (+7.9% YoY) but missed EPS expectations due to higher costs from acquisitions and clinic startups. Management is pursuing hospital partnerships and shifting toward private insurance, aiming to boost clinic utilization and reduce reliance on Medicare/Medicaid. I now rate U.S. Physical Therapy as hold, reflecting improved risk/reward at current valuation but acknowledging persistent structural challenges and margin pressures. Read the full article on Seeking AlphaRecent updates
Analysartikel • Jun 20
U.S. Physical Therapy (USPH) Stock Could Be 32.4% Undervalued After Profit Growth
U.S. Physical Therapy (USPH) is back in focus after recent financial disclosures showed 7.89% year-over-year revenue growth and net profit rising 115.29%, while analyst opinions and technical signals currently point in different directions for the stock. See our latest analysis for U.S. Physical Therapy. Despite the latest revenue and net profit figures, U.S. Physical Therapy’s 1-year total shareholder return declined 12.6% and the 5-year total shareholder return fell 41.7%, indicating fading...Uppdatering av berättelse • Jun 13
USPH: Hospital Alliances And Medicare Pricing Will Support Future Margin Upside
Analysts have lowered their price target on U.S. Physical Therapy to $90 from $103, citing somewhat lower profitability expectations and a higher projected net debt load following a mixed Q1 report. What's in the News From January 1, 2026 to March 31, 2026, U.S. Physical Therapy reported no share repurchases, with 0 shares bought for US$0 million under its existing buyback program (Key Developments).Uppdatering av berättelse • May 30
USPH: Hospital Alliances And Medicare Pricing Will Drive Future Margin Recovery
Analysts have trimmed their blended price target on U.S. Physical Therapy from about $107 to roughly $94, reflecting lower P/E assumptions and somewhat softer profitability expectations, along with higher net debt. They also note potential margin improvement supported by hospital alliances and improved Medicare rates.Seeking Alpha • May 22
U.S. Physical Therapy: The Valuation Reset Changes The Story (Rating Upgrade)
Summary U.S. Physical Therapy, Inc. has seen valuation multiples compress significantly despite continued revenue growth and new strategic initiatives. U.S. Physical Therapy reported Q1 2026 revenue of $198.3M (+7.9% YoY) but missed EPS expectations due to higher costs from acquisitions and clinic startups. Management is pursuing hospital partnerships and shifting toward private insurance, aiming to boost clinic utilization and reduce reliance on Medicare/Medicaid. I now rate U.S. Physical Therapy as hold, reflecting improved risk/reward at current valuation but acknowledging persistent structural challenges and margin pressures. Read the full article on Seeking AlphaAnalysartikel • Sep 12
These 4 Measures Indicate That U.S. Physical Therapy (NYSE:USPH) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Analysartikel • Aug 02
Pinning Down U.S. Physical Therapy, Inc.'s (NYSE:USPH) P/E Is Difficult Right Now
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...Analysartikel • Jul 11
U.S. Physical Therapy (NYSE:USPH) Is Reinvesting At Lower Rates Of Return
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...Analysartikel • Jun 10
Here's Why U.S. Physical Therapy (NYSE:USPH) Can Manage Its Debt Responsibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Analysartikel • May 14
Here's Why It's Unlikely That U.S. Physical Therapy, Inc.'s (NYSE:USPH) CEO Will See A Pay Rise This Year
Key Insights U.S. Physical Therapy's Annual General Meeting to take place on 20th of May CEO Chris Reading's total...Analysartikel • Mar 24
Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?
U.S. Physical Therapy, Inc. ( NYSE:USPH ), might not be a large cap stock, but it received a lot of attention from a...Analysartikel • Mar 01
U.S. Physical Therapy, Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Last week, you might have seen that U.S. Physical Therapy, Inc. ( NYSE:USPH ) released its yearly result to the market...Analysartikel • Feb 28
U.S. Physical Therapy (NYSE:USPH) Seems To Use Debt Quite Sensibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...Analysartikel • Jan 03
Capital Allocation Trends At U.S. Physical Therapy (NYSE:USPH) Aren't Ideal
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...Analysartikel • Nov 09
Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price
When close to half the companies in the Healthcare industry in the United States have price-to-sales ratios (or "P/S...
Ny berättelse • Sep 14
Tactical Contract Renegotiations And Innovative Recruitment Tactics Propel Revenue Growth And Margin Expansion
Innovations in recruitment and operational efficiencies are set to bolster net margins despite a tight labor market and high costs.Analysartikel • Aug 07
U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...Analysartikel • Jul 17
U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analysartikel • Jun 04
U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...Analysartikel • May 21
There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings
The market for U.S. Physical Therapy, Inc.'s ( NYSE:USPH ) shares didn't move much after it posted weak earnings...Analysartikel • May 11
U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44
The board of U.S. Physical Therapy, Inc. ( NYSE:USPH ) has announced that it will pay a dividend of $0.44 per share on...Analysartikel • May 05
Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Analysartikel • Apr 21
A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)
Key Insights Using the 2 Stage Free Cash Flow to Equity, U.S. Physical Therapy fair value estimate is US$113 U.S...Analysartikel • Apr 07
Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not have the largest market cap around , it saw a decent share...Analysartikel • Mar 04
U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit
When you see that almost half of the companies in the Healthcare industry in the United States have price-to-sales...Analysartikel • Dec 23
The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...Analysartikel • Dec 07
Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not be the most widely known stock at the moment, it saw a...Aktieägarnas avkastning
| USPH | US Healthcare | US Marknad | |
|---|---|---|---|
| 7D | -4.4% | 0.07% | -2.3% |
| 1Y | -19.7% | 19.3% | 21.2% |
Avkastning vs industri: USPH presterade sämre än US Healthcare branschen som gav 19.3 % under det senaste året.
Avkastning vs Marknaden: USPH presterade sämre än US marknaden som gav 21.2 % under det senaste året.
Prisvolatilitet
| USPH volatility | |
|---|---|
| USPH Average Weekly Movement | 7.4% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stabil aktiekurs: USPH har inte haft någon betydande prisvolatilitet under de senaste 3 månaderna jämfört med marknaden för US.
Volatilitet över tid: USPH s veckovolatilitet ( 7% ) har varit stabil under det senaste året.
Om företaget
| Grundad | Anställda | VD OCH KONCERNCHEF | Webbplats |
|---|---|---|---|
| 1990 | 6,374 | Chris Reading | www.usph.com |
U.S. Physical Therapy, Inc. driver och förvaltar tillsammans med sina dotterbolag kliniker för öppenvårdsfysioterapi. Verksamheten bedrivs genom två segment, Physical Therapy Operations och Industrial Injury Prevention Services. Bolaget tillhandahåller pre- och postoperativ vård och behandling för ortopedirelaterade sjukdomar, idrottsrelaterade skador, förebyggande vård, rehabilitering av skadade arbetare och neurologiska skador.
U.S. Physical Therapy, Inc. Sammanfattning av grunderna
| USPH grundläggande statistik | |
|---|---|
| Börsvärde | US$951.33m |
| Vinst(TTM) | US$7.67m |
| Intäkter(TTM) | US$787.69m |
126.0x
P/E-förhållande1.2x
P/S-förhållandeÄr USPH övervärderat?
Se Verkligt värde och värderingsanalysResultat & intäkter
| USPH resultaträkning (TTM) | |
|---|---|
| Intäkter | US$787.69m |
| Kostnad för intäkter | US$615.17m |
| Bruttovinst | US$172.52m |
| Övriga kostnader | US$164.85m |
| Intäkter | US$7.67m |
Senast redovisade vinst
Mar 31, 2026
Nästa vinstdatum
n/a
| Vinst per aktie (EPS) | 0.50 |
| Bruttomarginal | 21.90% |
| Nettovinstmarginal | 0.97% |
| Skuld/egenkapitalförhållande | 26.2% |
Hur har USPH utvecklats på lång sikt?
Se historisk utveckling och jämförelseUtdelningar
2.9%
Aktuell utdelningsavkastning358%
UtbetalningskvotFöretagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/06/23 12:57 |
| Aktiekurs vid dagens slut | 2026/06/23 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som används för att skapa denna rapport finns på vår Github-sida; vi har också guider om hur du använder våra rapporter och handledningar på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
U.S. Physical Therapy, Inc. bevakas av 15 analytiker. 7 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Michael Petusky | Barrington Research Associates, Inc. |
| Joanna Sylvia Gajuk | BofA Global Research |
| Joseph France | Cantor Fitzgerald & Co. |